Correlation Between RAMM Pharma and Biofrontera
Can any of the company-specific risk be diversified away by investing in both RAMM Pharma and Biofrontera at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RAMM Pharma and Biofrontera into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RAMM Pharma Corp and Biofrontera, you can compare the effects of market volatilities on RAMM Pharma and Biofrontera and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RAMM Pharma with a short position of Biofrontera. Check out your portfolio center. Please also check ongoing floating volatility patterns of RAMM Pharma and Biofrontera.
Diversification Opportunities for RAMM Pharma and Biofrontera
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between RAMM and Biofrontera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding RAMM Pharma Corp and Biofrontera in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofrontera and RAMM Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RAMM Pharma Corp are associated (or correlated) with Biofrontera. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofrontera has no effect on the direction of RAMM Pharma i.e., RAMM Pharma and Biofrontera go up and down completely randomly.
Pair Corralation between RAMM Pharma and Biofrontera
If you would invest 126.00 in Biofrontera on September 17, 2024 and sell it today you would lose (26.00) from holding Biofrontera or give up 20.63% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 1.54% |
Values | Daily Returns |
RAMM Pharma Corp vs. Biofrontera
Performance |
Timeline |
RAMM Pharma Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Biofrontera |
RAMM Pharma and Biofrontera Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with RAMM Pharma and Biofrontera
The main advantage of trading using opposite RAMM Pharma and Biofrontera positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RAMM Pharma position performs unexpectedly, Biofrontera can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofrontera will offset losses from the drop in Biofrontera's long position.RAMM Pharma vs. City View Green | RAMM Pharma vs. Speakeasy Cannabis Club | RAMM Pharma vs. Pure Harvest Cannabis | RAMM Pharma vs. Ravenquest Biomed |
Biofrontera vs. Shuttle Pharmaceuticals | Biofrontera vs. Akanda Corp | Biofrontera vs. China Pharma Holdings | Biofrontera vs. Sunshine Biopharma Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |